Literature DB >> 10642090

Rat dorsal root ganglia express m1-m4 muscarinic receptor proteins.

N Bernardini1, A I Levey, G Augusti-Tocco.   

Abstract

The distribution of m1-m4 muscarinic acetylcholine receptors was investigated by immunolight and electron microscopy in rat dorsal root ganglia, by using subtype-specific antibodies. The light microscopic observations show that both the intensity and the localisation of immunolabeling of the four muscarinic subtypes are different. The m2 receptor is the most represented; m2 and m4 receptor proteins are principally expressed in the small-medium type neurones, while m1 and m3 receptor proteins are more homogeneously distributed among the neuronal population of the ganglion. On the contrary, there are no relevant differences in the subcellular distribution. Ultrastructural analysis shows that immunolabeling is associated with the Nissl bodies, budding Golgi cisterns, and as far as the m2 receptor is concerned, just beneath the plasmalemma with discrete loci along the neuronal plasma membrane. Unmyelinated nerve fibres are always immunopositive for all muscarinic receptor subtypes, suggesting an active transport for all subtypes. Occasionally perineuronal satellite cells surrounding large neurones are immunopositive for the m2 receptor, while both myelinating and non-myelinating Schwann cells faintly express all muscarinic receptor subtypes. These observations, together with previous data concerning pharmacological and functional characterisation of muscarinic acetylcholine receptors in dorsal root ganglion, suggest that sensory neurones are able to respond to acetylcholine. The presence of m2 and m4 immunoreactivity in the small type neurones and in their fibres involved in nociceptive response, suggest that these receptors may participate in the modulation of transduction of noxious stimuli from the periphery to the spinal cord. m1 and m3 receptors, having a more homogeneously distribution, may be involved in transduction of different kinds of stimuli.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10642090

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  12 in total

1.  Excitatory nicotinic and desensitizing muscarinic (M2) effects on C-nociceptors in isolated rat skin.

Authors:  N Bernardini; S K Sauer; R Haberberger; M J Fischer; P W Reeh
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

2.  Diabetic neuropathy enhances voltage-activated Ca2+ channel activity and its control by M4 muscarinic receptors in primary sensory neurons.

Authors:  Xue-Hong Cao; Hee Sun Byun; Shao-Rui Chen; Hui-Lin Pan
Journal:  J Neurochem       Date:  2011-09-21       Impact factor: 5.372

3.  Selective antagonism of muscarinic receptors is neuroprotective in peripheral neuropathy.

Authors:  Nigel A Calcutt; Darrell R Smith; Katie Frizzi; Mohammad Golam Sabbir; Subir K Roy Chowdhury; Teresa Mixcoatl-Zecuatl; Ali Saleh; Nabeel Muttalib; Randy Van der Ploeg; Joseline Ochoa; Allison Gopaul; Lori Tessler; Jürgen Wess; Corinne G Jolivalt; Paul Fernyhough
Journal:  J Clin Invest       Date:  2017-01-17       Impact factor: 14.808

4.  Genetic reduction of muscarinic M4 receptor modulates analgesic response and acoustic startle response in a mouse model of fragile X syndrome (FXS).

Authors:  Surabi Veeraragavan; Deanna Graham; Nghiem Bui; Lisa A Yuva-Paylor; Jürgen Wess; Richard Paylor
Journal:  Behav Brain Res       Date:  2011-11-23       Impact factor: 3.332

5.  Role of M2, M3, and M4 muscarinic receptor subtypes in the spinal cholinergic control of nociception revealed using siRNA in rats.

Authors:  You-Qing Cai; Shao-Rui Chen; Hee-Dong Han; Anil K Sood; Gabriel Lopez-Berestein; Hui-Lin Pan
Journal:  J Neurochem       Date:  2009-09-23       Impact factor: 5.372

Review 6.  New pharmacological approaches to the cholinergic system: an overview on muscarinic receptor ligands and cholinesterase inhibitors.

Authors:  Nigel H Greig; Marcella Reale; Ada M Tata
Journal:  Recent Pat CNS Drug Discov       Date:  2013-08

Review 7.  Structural homology of myelin basic protein and muscarinic acetylcholine receptor: Significance in the pathogenesis of complex regional pain syndrome.

Authors:  Veronica I Shubayev; Alex Y Strongin; Tony L Yaksh
Journal:  Mol Pain       Date:  2018-11-05       Impact factor: 3.370

8.  Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation.

Authors:  Rodrigo R Resende; Avishek Adhikari
Journal:  Cell Commun Signal       Date:  2009-08-27       Impact factor: 5.712

9.  Dexmedetomidine inhibits muscarinic type 3 receptors expressed in Xenopus oocytes and muscarine-induced intracellular Ca2+ elevation in cultured rat dorsal root ganglia cells.

Authors:  Atsushi Takizuka; Kouichiro Minami; Yasuhito Uezono; Takafumi Horishita; Toru Yokoyama; Munehiro Shiraishi; Takeshi Sakurai; Akio Shigematsu; Yoichi Ueta
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-06-12       Impact factor: 3.195

10.  Muscarinic Toxin 7 Signals Via Ca2+/Calmodulin-Dependent Protein Kinase Kinase β to Augment Mitochondrial Function and Prevent Neurodegeneration.

Authors:  Ali Saleh; Mohammad Golam Sabbir; Mohamad-Reza Aghanoori; Darrell R Smith; Subir K Roy Chowdhury; Lori Tessler; Jennifer Brown; Eva Gedarevich; Markos Z Kassahun; Katie Frizzi; Nigel A Calcutt; Paul Fernyhough
Journal:  Mol Neurobiol       Date:  2020-03-20       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.